Indivior shares dive after Dr Reddy's gets FDA approval for generic

(Reuters) - Britain's Indivior fell by more than 20 percent on Friday after the U.S Food and Drug Administration (FDA) approved the first generic versions of Suboxone Film, an opioid addiction treatment that generates 80 percent of its revenue.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news

Related Links:

Publication date: Available online 17 October 2019Source: Progress in Neuro-Psychopharmacology and Biological PsychiatryAuthor(s): Di Wen, Rongji Hui, Yi Liu, Yixiao Luo, Jian Wang, Xi Shen, Bing Xie, Feng Yu, Bin Cong, Chunling MaAbstractMethamphetamine (METH) is one of the most prevalently used illegal psychostimulants in many countries. Continuous exposure to METH leads to behavioral sensitization in animals, which can be used as a behavioral model with many mechanisms in common with relapse in humans. Molecular hydrogen has recently gained attention for its potential as a novel healthcare product with preventive and th...
Source: Progress in Neuro Psychopharmacology and Biological Psychiatry - Category: Psychiatry Source Type: research
In this study, we examined the role of D1-like dopamine receptor (D1 DR) on spatial memory in the offspring of morphine-abstinent rats. Adult male and female rats received morphine orally for 21 days and were drug-free for ten days. The rats were prepared to mate and the offspring were divided into four groups: offspring of drug-naïve parents, offspring of maternal morphine-exposed, offspring of paternal morphine-exposed, and PME + MME group. Saline or SCH23390 was injected into the hippocampus and prefrontal (PFC), and the Morris Water Maze task was performed. Afterward, the rats were sacrificed, and ph...
Source: Neuroscience Research - Category: Neuroscience Source Type: research
FRIDAY, Oct. 18, 2019 -- Electronic cigarette use in England is positively associated with overall cigarette quit rates and quit success rates, according to a study published online Oct. 17 in Addiction. Emma Beard, Ph.D., from University College...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Funding Opportunity PAR-20-035 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is supported by Collaborative Research on Addiction (CRAN) at the National Institutes of Health (NIH), a trans-NIH partnership composed of the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA), and the National Cancer Institute (NCI). The intent of this FOA is two-fold: (1) characterize how the neurobiological alterations, associated behaviors, and public health consequences arising from polysubstance use differ from, or are similar to, those observed...
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding
This article provides a review of the preclinical and clinical pharmacology of lorcaserin, including its pharmacokinetic and safety profiles. Preclinical studies with lorcaserin initially focused on simple measures of food intake and body weight gain, but have now expanded to include studies on its effects on appetitive aspects of feeding behaviour and models of binge-eating. A significant number of studies have also shown that lorcaserin alters behaviours related to drug use and addiction, in rodents and non-human primates. Potential clinically-relevant effects of lorcaserin have also been reported in models of pain and s...
Source: Pharmacology and Therapeutics - Category: Drugs & Pharmacology Source Type: research
What is Red Ribbon Week? Red Ribbon Week is October 23-31, a time to get involved in the fight against drugs and bullying. This week-long campaign is celebrated in schools nationwide and provides an opportunity for parents, students, and concerned individuals to take a stand against the violence and drug dependency that can wreak havoc on communities and futures alike. The History of the Red Ribbon Campaign Red Ribbon Week began with the nonprofit organization National Family Partnership (NFP) as a result of the tragic murder of an undercover narcotics officer. In 1985, DEA agent Enrique Camarena was tortured to death by ...
Source: Cliffside Malibu - Category: Addiction Authors: Tags: Addiction Substance Abuse bullying child development children drug abuse and prevention drug addiction drugs red ribbon week Source Type: blogs
The Oregon Court of Appeals on Thursday temporarily halted new rules banning the sale of flavored vaping products, just two days after they went into effect. Gov. Kate Brown had ordered the ban to prevent youth and adults from exposure to health risks from vaping products and nicotine addiction. At least 33 people have died and nearly 1,500 have fallen ill from a vaping-related lung condition. In Oregon, 11 cases have been reported, two of which resul ted in death. The Oregon Health Authority put…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
TIME held its first TIME 100 Health Summit on Thursday aiming to define — and shape — the future of health care. The Summit, which is an offshoot of the magazine’s annual TIME 100 list of influential people, featured scientists, politicians and entertainers, such as former President Bill Clinton, former Vice President Al Gore, NIH Director Dr. Francis Collins, actress Selma Blair, NBA commissioner Adam Silver, comedian Tig Notaro and former Planned Parenthood President Dr. Leana Wen. The day included a range of interviews, panels and performances. Here are the biggest moments from the Summit. Former Vice ...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Comedy HealthSummit19 onetime Source Type: news
A new study from Rutgers University in New Jersey, found those recovering from opioid addiction were better at controlling cravings if they practiced mindfulness along with using methadone.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Conclusions: This study provides further evidence of the need to consider coaddictions and the usefulness of global addictive evaluations. Poor prognostic factors must alert the clinician to initiate more sustained care. Further implications are discussed.
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
More News: Addiction | Food and Drug Administration (FDA) | Health | Suboxone | UK Health